Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_assertion type Assertion NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_head.
- NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_assertion description "[HSP90 is functionally important for melanoma cells and HSP90 inhibitors such as ganetespib could potentially be effective therapeutics for melanoma with various genetic mutations and acquired resistance to B-RAF inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_provenance.
- NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_assertion evidence source_evidence_literature NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_provenance.
- NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_assertion SIO_000772 23418523 NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_provenance.
- NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_assertion wasDerivedFrom befree-20150227 NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_provenance.
- NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_assertion wasGeneratedBy ECO_0000203 NP705407.RAKZDHlVRfSfmQvnL6U8t65eW0rVXbqbk9RCbeLOsmd48130_provenance.